These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 401853

  • 21. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
    Marrie TJ, Gurwith MJ, Ronald AR, Stiver HG, Lank B, Fox L.
    Can Med Assoc J; 1977 Jul 23; 117(2):138-43. PubMed ID: 406032
    [Abstract] [Full Text] [Related]

  • 22. Gram negative bone and joint infection: sixty patients treated with amikacin.
    Schurman DJ, Wheeler R.
    Clin Orthop Relat Res; 1978 Jul 23; (134):268-74. PubMed ID: 365414
    [Abstract] [Full Text] [Related]

  • 23. Clinical experience with amikacin, a new aminoglycoside antibiotic.
    Theron FP, De Kock MA.
    S Afr Med J; 1977 May 21; 51(21):746-8. PubMed ID: 327583
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov 21; 134 SUPPL():S381-3. PubMed ID: 993631
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
    Mumtaz K, Munir S, Muddassir M, Raza A, Waqas K, Shoaib Ahmed S, Malik A, Haider Naqvi SZ.
    Pak J Pharm Sci; 2021 May 21; 34(3(Supplementary)):1111-1118. PubMed ID: 34602440
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ, Mandaleris CD, Sande MA.
    J Lab Clin Med; 1977 Apr 21; 89(4):692-701. PubMed ID: 321713
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA, Farrell W, Maskell J, Williams JD.
    Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196
    [Abstract] [Full Text] [Related]

  • 36. Overview of first-line amikacin therapy for urologic infections.
    Carson CC, Paulson DF, Rudd C.
    Am J Med; 1985 Jul 15; 79(1A):51-4. PubMed ID: 3927721
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS, Keys TF.
    Mayo Clin Proc; 1983 Feb 15; 58(2):99-102. PubMed ID: 6823164
    [Abstract] [Full Text] [Related]

  • 39. Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
    Montgomerie JZ, Morrow JW, Canawati HN, Gilmore DS, Graham IE, Ibraham MZ.
    Urology; 1986 Nov 15; 28(5):446-50. PubMed ID: 3787915
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M, Pechère JC, Marchou B, Auckenthaler R.
    Am J Med; 1986 Jun 30; 80(6B):138-42. PubMed ID: 3088999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.